Increased sympathetic activity in the pathogenesis of restraint ulcer in rats.
D000311:Adrenal Glands / Q000502:physiology; D000315:Adrenalectomy; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000818:Animals; D001949:Bretylium Compounds / Q000494:pharmacology; D005260:Female; D005753:Gastric Mucosa / Q000378:metabolism; D006207:Half-Life; D006892:Hydroxydopamines / Q000494:pharmacology; D007103:Immobilization; D066298:In Vitro Techniques; D008750:Methyldopa / Q000494:pharmacology; D009638:Norepinephrine / Q000378:metabolism; D010643:Phenoxybenzamine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D051381:Rats; D013276:Stomach Ulcer / Q000209:etiology / Q000503:physiopathology*; D013312:Stress, Physiological / Q000150:complications; D013363:Submandibular Gland / Q000378:metabolism; D013564:Sympathetic Nervous System / Q000503:physiopathology*; D014316:Tritium
D000317:Adrenergic alpha-Antagonists; D001949:Bretylium Compounds; D006892:Hydroxydopamines; D010643:Phenoxybenzamine; D014316:Tritium; D008750:Methyldopa; D009638:Norepinephrine; D010646:Phentolamine